CAS: 594-70-7; 2-Methyl-2-Nitropropane

该化合物是一种有机化合物,其特点是硝基和烷基功能组;一种一般用作溶剂和有机合成的无色的淡黄色液体;2-甲基-2-硝基丙烷的分子式为C5H11NO2,表明存在5个碳原子,11个氢原子,1个氮原子和2个氧原子;该化合物的沸点相对较低,密度低于水;以其正常状态下的稳定性为著称,但可发生典型的硝基化合物反应,如减少或核细胞替代;由于硝基化合物的出现,该化合物还可能表现出某种极性,影响其在不同溶剂中的溶解性;在处理该化合物时,应当采取安全防范措施,因为硝基化合物可能具有危险性.

结构式图片

相似化合物

10017-37-5 60469-70-7 6045-08-5

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

Isobutane 2,2-dimethylpropane tertiary butyl chloride t-butyl bromide tert-butylaminetert-butylamine di-tert-butyl nitroxide N-tert-butyl-N-phenylhydroxylamine N-tert.-Butyl-N-(2,6-dimethoxy-phenyl)-hydroxylamin

合成工艺路线路线简述

    三甲基乙酸置于nitronium Tetrafluoborate,Silver Carbonate体系中,用 N,N-二甲基乙酰胺 作为反应溶剂,化学反应 12.0H,以79%的收率获得产物2-甲基-2-硝基丙烷
    参考文献:银(i)促进的ipso羧酸由四氟硼酸硝的-Nitration
    标题:银(i)促进的ipso羧酸由四氟硼酸硝的-Nitration
    摘要:已经描述了使用四氟硼酸硝基鎓和碳酸银在二甲基乙酰胺中将一系列脂族和芳族羧酸区域选择性硝化为它们相应的硝基化合物的新颖而有效的方法.据信这种转化是通过烷基-银或芳基-银中间体进行的,该中间体随后与硝鎓离子反应形成硝基物质.温和的反应条件下,宽范围的官能团的耐受性,并形成仅的本位相比,硝基烷基和硝基芳烃的合成公知的方法时-Nitrated产品是这种方法的关键特征.
    DOI:10.1021/acs.Joc.5B02133

    海关参考信息

    专利信息


    专利号:US-2022356182-A1
    优先权日:2009-03-27
    标题 :Inhibitors of hepatitis c virus replication
    发明人:COBURN CRAIG A; LUDMERER STEVEN W; LIU KUN; WU HAO; SOLL RICHARD; ZHONG BIN; ZHU JIAN
    权利人:MERCK SHARP & DOHME
    摘要:The present invention relates to compounds of formula (I) that are useful as hepatitis C virus (HCV) NS5A inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5A activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system.

    专利号:US-9440991-B2
    优先权日:2013-12-23
    标 题:Synthesis of an antiviral compound
    发明人:CAGULADA AMY; CHAN JOHANN; CHAN LINA; COLBY DENISE A; KARKI KAPIL KUMAR; KATO DARRYL; KEATON KATIE ANN; KONDAPALLY SUDHA; LEVINS CHRIS; LITTKE ADAM; MARTINEZ RUBEN; PCION DOMINIKA; REYNOLDS TROY; ROSS BRUCE; SANGI MICHAEL; SCHRIER ADAM J; SENG PAMELA; SIEGEL DUSTIN; SHAPIRO NATHAN; TANG DONALD; TAYLOR JAMES G; TRIPP JONATHAN; WALTMAN ANDREW W; YU LAWRENCE
    权利人:GILEAD SCIENCES INC
    摘要:The present disclosure provides processes for the preparation of a compound of formula I: n nwhich is useful as an antiviral agent. The disclosure also provides compounds and processes for the preparation of the compounds that are synthetic intermediates to the compound of formula I.

    专利号:US-9670134-B2
    优先权日:2013-03-28
    标 题:Synthesis of (2-nitro)alkyl (meth)acrylates via transesterification of (meth)acrylate esters
    发明人:SATHIOSATHAM MUHUNTHAN; WILCZYNSKI ROBERT
    权利人:ANGUS CHEMICAL
    摘要:Provided is a process for making (2-nitro)alkyl (meth)acrylate compounds of formula I: wherein n, R, R 1 , R 2 , R 3 , R 4 , R 6 , R 7 , and n are as defined herein, by a transesterification reaction between a nitroalcohol compound and a (meth)acrylate compound in the presence of a transesterification catalyst and a free radical inhibitor.

    专利号:US-9090661-B2
    优先权日:2009-03-27
    标 题:Inhibitors of hepatitis C virus replication
    发明人:COBURN CRAIG A; MCCAULEY JOHN A; LUDMERER STEVEN W; LIU KUN; VACCA JOSEPH P; WU HAO; HU BIN; SOLL RICHARD; SUN FEI; WANG XINGHAI; YAN MAN; ZHANG CHENGREN; ZHENG MINGWEI; ZHONG BIN; ZHU JIAN
    权利人:MERCK SHARP & DOHME
    摘要:The present invention relates to compounds of formula (I) that are useful as hepatitis C virus (HCV) NS5A inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5A activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system.

    专利号:US-10947203-B2
    优先权日:2016-03-25
    标题 :1,4,5-substituted 1,2,3-triazole analogues as antagonists of the pregnane X receptor
    发明人:CHEN TAOSHENG; LIN WENWEI; WANG YUEMING
    权利人:ST JUDE CHILDRENS RES HOSPITAL; ST JUDE CHILDRENS RSEARCH HOSPITAL
    摘要:In an aspect, the invention relates to 1,4,5-substituted 1,2,3-triazole and 1,2,4,5-substituted imidazoles having a structure represented by a formula: n nwhich are modulators the pregnane X receptor (“PXRâ€?); synthesis methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of modulating an adverse drug reaction in a mammal using the compounds and pharmaceutical compositions; methods of treatment of a disorder of uncontrolled cellular proliferation, such as a cancer, using the compounds and pharmaceutical compositions; methods of modulating pregnane X receptor activity in a mammal using the compounds and pharmaceutical compositions. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

    专利号:US-2017210756-A1
    优先权日:2013-12-23
    标题 :Synthesis of an antiviral compound
    北京偶合科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.ouhechem.com
    企业联系电话:010-51280831(不占线);010-82967028👤
    📞北京偶合科技有限公司 ⚠️参考联系方式
    联系人:刘先生
    电话:010-51280831(不占线);010-82967028
    手机:13911808554
    传真:010-82967029
    邮箱:sales@ouhechem.com
    通信地址: 北京市海淀区西三旗桥东上奥世纪2b-1328室
    邮编: 100096
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:北京市海淀区西三旗桥东上奥世纪2b-1328室
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    [参考文献]: Sumana Sengupta, Et Al. Photodissociation Dynamics Of 2-Nitropropane And 2-Methyl-2-Nitropropane At 248 And 193 Nm. J Phys Chem A. 2008 Dec 11;112(49):12572-81.

    合成参考文献


    摘要:Sato, N., Science of Synthesis Knowledge Updates, (2011) 4, 325.
    摘要:Liang, Y.; Wen, Z.; Cabrera, M.; Howlader, A. H.; Wnuk, S. F., Science of Synthesis Knowledge Updates, (2020) 1, 264.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知